baughman4

On May 1, 2000, the law firm of Waters and Kraus [23] of Dallas filed
the first of several class action suits charging that the APA, CHADD and
Ciba-Giegy/Novartis:

" planned, conspired, and colluded to create, develop, promote and
confirm the diagnoses of Attention Deficit Disorder and Attention
Deficit Hyperactivity Disorder, in a highly successful effort to
increase the market for its product Ritalin."

Perhaps now, Ladies and Gentlemen, you can understand why the 'halls of
justice,' not psychiatric 'science,' are necessary to give us the
answers we so urgently need, to end the awful epidemic of psychiatric
'diseases' and drugging that effects millions of US schoolchildren
today, as none other in the world.

BIBLIOGRAPHY

1. Los Angeles Times, Editorial, October 27, 2000.
2. The American Academy of Neurology: The First Fifty Years, 1948-1998.
Maynard M. Cohen (ed.). The American Academy of Neurology, St. Paul,
MN.
3. Letter from Cornelius E. Gallagher, Chairman of the Right to Privacy
Inquiry Special Studies Subcommittee to the Honorable Elliott
Richardson, Secretary Department of Health Education and Welfare (HEW)
October 12, 1970.
4. American Psychiatric Association. Diagnostic and statistical manual
of mental disorders, 3rd edition. Washington: American Psychiatric
Association, 1980.
5. American Psychiatric Association. Diagnostic and Statistical Manual
of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC.
1987.
6. American Psychiatric Association. Diagnostic and Statistical Manual
of Mental Disorders, 4th edition. Washington, DC. 1994.
7. Pearlman, T. Letter to the editor in Clinical Psychiatric News
December, 1994.
8. Schiller E, Jensen PS, Swanson J. In magazine of the Parent Teachers
Association, from the Office of Special Education, US Department of
Education,1996.
9. Christopher Shays, R-CN at the Hearing of the Committee on Government
Reform and Oversight, July 15, 1996.
10. Diller, L. personal correspondence to S. Parry, October 8, 1997.
11. Castellanos, FX. Personal correspondence to F.Baughman of May, 13,
1998.
12. Hyman SE. Opening remarks at the November 16-18, 1998, NIH,
Consensus Conference on ADHD.
13. Carey, WB. Invited presentation: "Is ADHD a Valid Disorder" at the
November 16-18, 1998, NIH, Consensus Conference on ADHD.
14. DeGrandpre, R. Quoted at the November 16-18, 1998, NIH, Consensus
Conference on ADHD.
15. Baughman, FA Jr. Testimony at the NIH, Consensus Conference on
ADHD, November 17, 1998.
16. Final Statement of the Panel of the NIH, Consensus Conference on
ADHD, November 18, 1998.
17. Goldman LS, Genel M, Bezman RJ, Slanetz PJ, for the Council on
Scientific Affairs, American Medical Association. JAMA. 1998;
279:1100-1107.
18. Baughman, F.A. Jr. Treatment of Attention-Deficit/Hyperactivity
Disorder. JAMA. 1999;281:1490.
19. Baughman, FA Jr., letter to Matthew D. Cohen, Esq., President,
CHADD, November 28, 1999.
20. Report on Mental Health of the Surgeon General, December 13, 1999.
21. Baughman FA Jr., letter to Surgeon General, David Satcher, December
13, 1999.
22. Castellanos, FX. Interview in Making Sense of Ritalin, Readers
Digest, January, 2000.
23. Law firm of Waters and Kraus, Dallas, Texas, on <ritalinfraud.com>